We analyzed data from the German CML-Study IV, a randomized five-arm treatment optimization study in newly diagnosed BCR-ABL-positive chronic myeloid leukemia in chronic phase. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.